e-ISSN:2320-1215 p-ISSN: 2322-0112
Articles published in Research & Reviews in Pharmacy and Pharmaceutical Sciences have been cited by esteemed scholars and scientists all around the world. Research & Reviews in Pharmacy and Pharmaceutical Sciences has got h-index 9, which means every article in Research & Reviews in Pharmacy and Pharmaceutical Sciences has got 9 average citations.
Following are the list of articles that have cited the articles published in Research & Reviews in Pharmacy and Pharmaceutical Sciences.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
40 | 74 | 13 | 19 | 16 |
Year wise citations received |
39 | 63 | 13 | 19 | 18 |
Journal total citations count | 181 |
Journal impact factor | 0.88 |
Journal 5 years impact factor | 0.77 |
Journal cite score | 0.70 |
Journal h-index | 9 |
Journal h-index since 2018 | 6 |
Journal Impact Factor 2020 formula |
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
Journal 5-year Impact Factor 2020 formula |
Citations(2018 + 2019 + 2020 + 2021 + 2022)/ {Published articles(2018 + 2019 + 2020 + 2021 + 2022)} |
Journal citescore |
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Impact of verbal and web-based patient education programs driven by clinical pharmacist on the adherence and illness perception of hypertensive patients
|
|
Mini review on dengue fever
|
|
Mini review on dengue fever
|
|
Indoor risks of pesticide uses are significantly linked to hazards of the family members
|
|
Pharmacovigilance for drug safety monitoring
|
|
Pharmacovigilance for drug safety monitoring
|
|
Pharmacovigilance for drug safety monitoring
|
|
Silver nanoparticles: the good, the bad and the future
|
|
A review literature on pharmacology
|
|
Novel drug delivery approach in cancer therapy
|
|
Ebola virus: ancient virus on a recent outbreak
|
|
Pre and post compression studies of tablets
|
|
Panoramic view on quality by design
|
|
Analytical qbd approach first order model - robust rp-hplc method for simultaneous assessment of alogliptin and metformin
|
|
Quality by design: a paradigm for industry
|
|
Glances into the realm of quality by design (qbd) inpharmaceuticals
|
|
Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (qbd) approach for formulation development of novel dosage forms for effective drug therapy
|
|
Formulation, process, and storage strategies for lyophilizates of lipophilic nanoparticulate systems established based on the two models paliperidone palmitate and solid lipid nanoparticles.
|
|
Biotechnological production and practical application of l-asparaginase enzyme.
|
|
Microspheres - novel drug carriers
|
|